A resolution supporting the mission and goals of National Fentanyl Awareness Day in 2024, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.
Latest Action
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3739; text: CR S3720-3721)
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™Senate Resolution 692 from the 118th Congress is a non-binding resolution supporting the mission and goals of National Fentanyl Awareness Day in 2024. The resolution emphasizes increasing awareness among individuals and the public about the dangers posed by fake or counterfeit fentanyl pills, particularly their impact on families and young people. It was submitted and agreed to in the Senate without amendments or opposition. The resolution falls under the health policy area and aims to promote education and awareness rather than impose new laws or regulations.
S.Res. 692 is a Senate resolution endorsing National Fentanyl Awareness Day to raise public awareness about counterfeit fentanyl pills and their risks, especially to youth and families, passed unanimously but carries no binding legal authority.
- The resolution supports National Fentanyl Awareness Day in 2024 to highlight the dangers of counterfeit fentanyl pills.
- It focuses on increasing awareness among individuals and the public about the impact of fake fentanyl on families and young people.
- The resolution was agreed to unanimously in the Senate without amendments, indicating broad bipartisan support.
['Families affected by fentanyl-related incidents', 'Young people at risk of exposure to counterfeit fentanyl', 'Public health organizations and advocates focused on drug awareness', 'Government agencies involved in health education and drug prevention']
['As a non-binding resolution, it does not allocate funding or create enforceable mandates, which may limit its practical impact.', 'The resolution relies on awareness efforts, which may require coordination among multiple agencies and organizations without specified oversight mechanisms.', 'No detailed implementation plan or metrics for measuring increased awareness are included.']
The resolution was introduced and passed in the Senate during the 118th Congress, reflecting ongoing legislative attention to the opioid crisis and the specific threat posed by counterfeit fentanyl pills. It aligns with broader public health efforts to combat opioid misuse and raise awareness about drug safety without proposing new regulatory or funding measures.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased public and individual awareness could lead to greater community engagement in drug prevention efforts.', 'Potentially improved cooperation among health organizations and government agencies in addressing fentanyl-related risks.', 'Heightened media and educational focus on counterfeit fentanyl dangers may influence future policy discussions.']
The resolution does not include funding or enforcement provisions, limiting direct government action. Transparency considerations include monitoring how awareness campaigns are implemented following the resolution and whether measurable outcomes are reported. Since the resolution passed unanimously, it reflects consensus but should be tracked for follow-up actions or related legislation that may carry more substantive policy changes.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.